Fuse Medical Inc (FZMD) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fuse Medical Inc   (FZMD)


Fuse Medical Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fuse Medical Inc's ROI in the second quarter of 2023?
Fuse Medical Inc achieved a return on average invested assets (ROI) of 49.21 % in its second quarter of 2023 a new company high.

ROI has improved compared to 43.08% in the first quarter of 2023, due to net income growth.

Within the Healthcare sector 23 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2023 quarter, so far to 88, from total ROI ranking in the first quarter of 2023 at 95.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM -10.92 % -14.87 % -16.36 % -17.4 % -15.31 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 7 7 7 8 8
Return On Investment (TTM) 49.21 % 43.08 % 40.18 % -10.22 % -18.13 %
FZMD's Overall Ranking # 88 # 95 # 100 # 0 # 0
Seq. Investment Change TTM -1.58 % -2.82 % -3.1 % -3.89 % -5.93 %
Seq. Net Income Change TTM 12.42 % 4.19 % - - -
Net Income (TTM) in Millions 4 3 3 -1 -2

FZMD Company Profile >> Back to FZMD Roi Comparisons >> See Annual FZMD Return On Investment



Return On Investment FZMD's Ranking
Within: No.
Industry # 5
Sector # 24
Overall # 88

Return On Investment Statistics
High Average Low
49.21 %
-97.54 %
-1227.12 %
(Jun 30 2023)   (March 31, 2016)







Financial Statements
Fuse Medical Inc's II. Quarter Investments $ 7 Millions FZMD's Balance sheet
Fuse Medical Inc's II. Quarter Income $ 0 Millions Quarterly FZMD's Income Statement
FZMD's Income by Division See FZMD's Income by Division


FZMD Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 7 8 10 10 15
Y / Y Investment Growth -11.81 % -16.57 % -3.84 % -30.73 % 33.61 %
Net Income in Millions 3 -2 -1 -3 4
Y / Y Net Income Growth - - - - 465.63 %
Annual Return On Investment 42.01 % -18.99 % -14.29 % -31.82 % 26.3 %


Annual Roi Comment
In the fiscal year 2022 ROI improved to 42.01 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FZMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FZMD's Competitors
Subscribers only: Roi for Fuse Medical Inc's Suppliers
Subscribers only: Return On Investment for FZMD's Customers

Other Ratios
FZMD's Roa FZMD's Inventory Turnover Ratio FZMD's Growth Rates FZMD's Dividend Statistics
FZMD's Profitability Ratios FZMD's Asset Turnover Ratio FZMD's Dividend Growth
FZMD's Roe FZMD's Valuation Ratios FZMD's Financial Strength Ratios FZMD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Molecular Templates Inc   105.40 %
Chimerix Inc   71.97 %
Intercept Pharmaceuticals inc   66.44 %
Biomx Inc  64.84 %
Dariohealth Corp   55.27 %
Kiniksa Pharmaceuticals International Plc  55.10 %
Opus Genetics Inc   54.45 %
Scynexis Inc   53.53 %
Star Equity Holdings Inc   50.28 %
Fuse Medical Inc   49.21 %
Voyager Therapeutics Inc   48.99 %
Idexx Laboratories Inc  46.22 %
Shockwave Medical Inc   41.08 %
Entera Bio Ltd   40.58 %
Zymeworks Inc   40.51 %
Medpace Holdings Inc   40.02 %
Gyre Therapeutics Inc   39.45 %
Cv Sciences Inc   38.71 %
Revelation Biosciences Inc   37.76 %
Vaso Corporation  36.33 %
Mettler toledo International Inc   35.12 %
Tenax Therapeutics Inc   35.08 %
Catalyst Pharmaceuticals Inc   34.24 %
Enzo Biochem Inc  33.97 %
Harmony Biosciences Holdings inc   32.96 %
Assertio Holdings inc   32.25 %
Denali Therapeutics Inc   30.56 %
Semler Scientific inc   30.26 %
Nrc Health  30.00 %
Tao Synergies Inc   29.39 %

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.